OTCMKTS:NWCI - Newcardio Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0033 0.00 (0.00 %) (As of 05/22/2019 08:00 AM ET)Previous Close$0.0033Today's Range$0.0017 - $0.003452-Week Range$0.0006 - $0.0082Volume27,622 shsAverage Volume9,350 shsMarket Capitalization$134,673.00P/E RatioN/ADividend YieldN/ABeta7.39 ProfileChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey. Receive NWCI News and Ratings via Email Sign-up to receive the latest news and ratings for NWCI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NWCI Previous Symbol CUSIPN/A CIKN/A Webhttp://www.newcardio.com/ Phone510-774-1969Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees10 Outstanding Shares40,810,000Market Cap$134,673.00 Next Earnings DateN/A OptionableNot Optionable Newcardio (OTCMKTS:NWCI) Frequently Asked Questions What is Newcardio's stock symbol? Newcardio trades on the OTCMKTS under the ticker symbol "NWCI." Has Newcardio been receiving favorable news coverage? News stories about NWCI stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Newcardio earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Newcardio's key competitors? Some companies that are related to Newcardio include SpectraScience (SCIE), Guided Therapeutics (GTHP), Echo Therapeutics (ECTE), Magna-Lab (MAGAA), 21st North (ULGX), IMRIS (IMRSQ), Nexeon Medsystems (NXNND) and Vision Sciences (CGNT). What other stocks do shareholders of Newcardio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Newcardio investors own include SRG Graphite (SRG), Largo Resources (LGO), Bedrocan Cannabis (BED), Pure Global Cannabis (PRCNF), Occidental Petroleum (OXY), Crestwood Equity Partners (CEQP), Pieris Pharmaceuticals (PIRS), Krystal Biotech (KRYS), Galectin Therapeutics (GALT) and Citius Pharmaceuticals (CTXR). Who are Newcardio's key executives? Newcardio's management team includes the folowing people: Dr. Jess Emery Jones M.D., CEO & Director (Age 40)Mr. Greg Sadowski, Chief Operating Officer How do I buy shares of Newcardio? Shares of NWCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Newcardio's stock price today? One share of NWCI stock can currently be purchased for approximately $0.0033. How big of a company is Newcardio? Newcardio has a market capitalization of $134,673.00. Newcardio employs 10 workers across the globe. What is Newcardio's official website? The official website for Newcardio is http://www.newcardio.com/. How can I contact Newcardio? Newcardio's mailing address is 2350 MISSION COLLEGE BLVD. #1175, SANTA CLARA CA, 95054. The company can be reached via phone at 510-774-1969 or via email at [email protected] MarketBeat Community Rating for Newcardio (OTCMKTS NWCI)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 27 (Vote Outperform)Underperform Votes: 23 (Vote Underperform)Total Votes: 50MarketBeat's community ratings are surveys of what our community members think about Newcardio and other stocks. Vote "Outperform" if you believe NWCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NWCI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: Ex-Dividend Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.